Topline Results Announced from Trial of Non-Pharmacological Treatment for Osteopenia

December 1, 2022

Bone Health Technologies (BHT) announced yesterday topline results of its pivotal trial of the Osteoboost Vibration Belt. The results found that using Osteoboost more than three times per week in each of four quarters provided a statistically significant reduction in the loss of vertebral bone strength among participants— with no reported device-related serious adverse events. […]

To view the full Member Resource, please Log in

TOPICS IN THIS ARTICLE:

←Endocrine Society Urges Congress to Complete NIH Appropriations by December 16th Deadline

Repainting the Pituitary Landscape→

View Archives

Join the Global Movement Advancing Endocrine Science and Medicine

Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.

Join Today